The Transcribed-Ultra Conserved Regions: Novel non-coding RNA players in neuroblastoma progression

Nithya Mudgapalli, Brianna P. Shaw, Srinivas Chava, Kishore B. Challagundla

Research output: Contribution to journalReview article

Abstract

The Transcribed-Ultra Conserved Regions (T-UCRs) are a class of novel non-coding RNAs that arise from the dark matter of the genome. T-UCRs are highly conserved between mouse, rat, and human genomes, which might indicate a definitive role for these elements in health and disease. The growing body of evidence suggests that T-UCRs contribute to oncogenic pathways. Neuroblastoma is a type of childhood cancer that is challenging to treat. The role of non-coding RNAs in the pathogenesis of neuroblastoma, in particular for cancer development, progression, and therapy resistance, has been documented. Exosmic non-coding RNAs are also involved in shaping the biology of the tumor microenvironment in neuroblastoma. In recent years, the involvement of T-UCRs in a wide variety of pathways in neuroblastoma has been discovered. Here, we present an overview of the involvement of T-UCRs in various cellular pathways, such as DNA damage response, proliferation, chemotherapy response, MYCN (v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian)) amplification, gene copy number, and immune response, as well as correlate it to patient survival in neuroblastoma.

Original languageEnglish (US)
Article number39
JournalNon-coding RNA
Volume5
Issue number2
DOIs
StatePublished - Jan 1 2019

Fingerprint

Untranslated RNA
Neuroblastoma
Genes
Chemotherapy
Rats
Tumors
Health
Tumor Microenvironment
Gene Dosage
DNA
Human Genome
Oncogenes
DNA Damage
Neoplasms
Genome
Drug Therapy
Survival

Keywords

  • Biomarkers
  • Exosomes
  • MYCN
  • Metastasis
  • MicroRNAs
  • Neuroblastoma
  • Oncogenes
  • Therapy resistance
  • Transcribed-ultra conserved regions

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Genetics

Cite this

The Transcribed-Ultra Conserved Regions : Novel non-coding RNA players in neuroblastoma progression. / Mudgapalli, Nithya; Shaw, Brianna P.; Chava, Srinivas; Challagundla, Kishore B.

In: Non-coding RNA, Vol. 5, No. 2, 39, 01.01.2019.

Research output: Contribution to journalReview article

@article{2881b00715af4681ae34e7cfa5a30642,
title = "The Transcribed-Ultra Conserved Regions: Novel non-coding RNA players in neuroblastoma progression",
abstract = "The Transcribed-Ultra Conserved Regions (T-UCRs) are a class of novel non-coding RNAs that arise from the dark matter of the genome. T-UCRs are highly conserved between mouse, rat, and human genomes, which might indicate a definitive role for these elements in health and disease. The growing body of evidence suggests that T-UCRs contribute to oncogenic pathways. Neuroblastoma is a type of childhood cancer that is challenging to treat. The role of non-coding RNAs in the pathogenesis of neuroblastoma, in particular for cancer development, progression, and therapy resistance, has been documented. Exosmic non-coding RNAs are also involved in shaping the biology of the tumor microenvironment in neuroblastoma. In recent years, the involvement of T-UCRs in a wide variety of pathways in neuroblastoma has been discovered. Here, we present an overview of the involvement of T-UCRs in various cellular pathways, such as DNA damage response, proliferation, chemotherapy response, MYCN (v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian)) amplification, gene copy number, and immune response, as well as correlate it to patient survival in neuroblastoma.",
keywords = "Biomarkers, Exosomes, MYCN, Metastasis, MicroRNAs, Neuroblastoma, Oncogenes, Therapy resistance, Transcribed-ultra conserved regions",
author = "Nithya Mudgapalli and Shaw, {Brianna P.} and Srinivas Chava and Challagundla, {Kishore B.}",
year = "2019",
month = "1",
day = "1",
doi = "10.3390/NCRNA5020039",
language = "English (US)",
volume = "5",
journal = "Non-coding RNA",
issn = "2311-553X",
publisher = "MDPI AG",
number = "2",

}

TY - JOUR

T1 - The Transcribed-Ultra Conserved Regions

T2 - Novel non-coding RNA players in neuroblastoma progression

AU - Mudgapalli, Nithya

AU - Shaw, Brianna P.

AU - Chava, Srinivas

AU - Challagundla, Kishore B.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - The Transcribed-Ultra Conserved Regions (T-UCRs) are a class of novel non-coding RNAs that arise from the dark matter of the genome. T-UCRs are highly conserved between mouse, rat, and human genomes, which might indicate a definitive role for these elements in health and disease. The growing body of evidence suggests that T-UCRs contribute to oncogenic pathways. Neuroblastoma is a type of childhood cancer that is challenging to treat. The role of non-coding RNAs in the pathogenesis of neuroblastoma, in particular for cancer development, progression, and therapy resistance, has been documented. Exosmic non-coding RNAs are also involved in shaping the biology of the tumor microenvironment in neuroblastoma. In recent years, the involvement of T-UCRs in a wide variety of pathways in neuroblastoma has been discovered. Here, we present an overview of the involvement of T-UCRs in various cellular pathways, such as DNA damage response, proliferation, chemotherapy response, MYCN (v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian)) amplification, gene copy number, and immune response, as well as correlate it to patient survival in neuroblastoma.

AB - The Transcribed-Ultra Conserved Regions (T-UCRs) are a class of novel non-coding RNAs that arise from the dark matter of the genome. T-UCRs are highly conserved between mouse, rat, and human genomes, which might indicate a definitive role for these elements in health and disease. The growing body of evidence suggests that T-UCRs contribute to oncogenic pathways. Neuroblastoma is a type of childhood cancer that is challenging to treat. The role of non-coding RNAs in the pathogenesis of neuroblastoma, in particular for cancer development, progression, and therapy resistance, has been documented. Exosmic non-coding RNAs are also involved in shaping the biology of the tumor microenvironment in neuroblastoma. In recent years, the involvement of T-UCRs in a wide variety of pathways in neuroblastoma has been discovered. Here, we present an overview of the involvement of T-UCRs in various cellular pathways, such as DNA damage response, proliferation, chemotherapy response, MYCN (v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian)) amplification, gene copy number, and immune response, as well as correlate it to patient survival in neuroblastoma.

KW - Biomarkers

KW - Exosomes

KW - MYCN

KW - Metastasis

KW - MicroRNAs

KW - Neuroblastoma

KW - Oncogenes

KW - Therapy resistance

KW - Transcribed-ultra conserved regions

UR - http://www.scopus.com/inward/record.url?scp=85069899935&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85069899935&partnerID=8YFLogxK

U2 - 10.3390/NCRNA5020039

DO - 10.3390/NCRNA5020039

M3 - Review article

AN - SCOPUS:85069899935

VL - 5

JO - Non-coding RNA

JF - Non-coding RNA

SN - 2311-553X

IS - 2

M1 - 39

ER -